Results 111 to 120 of about 5,988 (201)

Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Pancreatic cancer is associated with a high risk of venous thromboembolism (VTE), with approximately one in five patients developing VTE. Randomized controlled trials have demonstrated that primary thromboprophylaxis is effective and safe in ambulatory patients with pancreatic cancer treated with chemotherapy.
Ruth A. L. Willems   +13 more
wiley   +1 more source

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study

open access: yesBMC Medicine
Background Several antiarrhythmic drugs can interact with direct oral anticoagulants (DOACs) through pharmacokinetic mechanisms increasing DOAC levels. Our multinational cohort study assessed the effectiveness and safety of concomitant use of DOACs and ...
Fabian Maximilian Meinert   +5 more
doaj   +1 more source

Evaluation of Treatment Response of Calcified Nodules and Nodular Calcified Lesions Using Mean Density on Coronary Computed Tomography Angiography

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1306-1316, October 1, 2026.
ABSTRACT Background Calcified nodules (CN) and nodular calcifications (NC) present significant challenges during percutaneous coronary intervention (PCI) because of their protruding morphology and high rigidity, which often result in inadequate stent expansion and suboptimal procedural outcomes.
Akito Setoguchi   +7 more
wiley   +1 more source

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1380-1385, October 1, 2026.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß   +14 more
wiley   +1 more source

Treatment of Deep Vein Thrombosis in Congenital Factor VII Deficiency: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Managing thrombosis in patients with bleeding disorders requires careful assessment of thromboembolic and bleeding risks, tailoring antithrombotic treatment in terms of type, dose, and duration, and considering the need for replacement therapy based on individual factor levels and bleeding history.
Synnøve Gjelsten Mortensen   +4 more
wiley   +1 more source

The Regionalization of High‐Volume Cardiac Pacing: A Prospective Cohort Study on Safety, Feasibility, and the Learning Curve in a Geriatric Population

open access: yesClinical Cardiology, Volume 49, Issue 10, October 2026.
This prospective study demonstrates that regionalized high‐volume cardiac pacing programmes, supported by structured mentorship, are safe and efficient. Regional centres can successfully navigate the surgical learning curve, achieving safety outcomes non‐inferior to tertiary standards while eliminating geographical barriers for elderly patients ...
Sergejs Pikta   +4 more
wiley   +1 more source

Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment

open access: yesCancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Purpose Men with prostate cancer have a high risk for bleeding when treated with antithrombotics. The aim of this study was to investigate clinical markers for vulnerability for bleeding in these men the last year of life. Methods This is a retrospective study on deceased patients with advanced prostate cancer admitted to specialized ...
Linda Björkhem‐Bergman   +3 more
wiley   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part IV) on Comprehensive Lifestyle Risk Factor and Comorbidity Management in Atrial Fibrillation

open access: yesJournal of Arrhythmia, Volume 42, Issue 5, October 2026.
ABSTRACT Atrial fibrillation (AF) is closely associated with comorbidities and lifestyle factors that influence the development, progression, and outcomes. Here the focus is on guidelines for the systematic management of hypertension, heart failure, coronary and structural heart disease, diabetes, dyslipidemia, cerebrovascular disease, obesity, chronic
Eue‐Keun Choi   +16 more
wiley   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part II) on Stroke Prevention in Atrial Fibrillation

open access: yesJournal of Arrhythmia, Volume 42, Issue 5, October 2026.
ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifestyle risk factor and comorbidity ...
Tze‐Fan Chao   +15 more
wiley   +1 more source

Evaluating Acute Ischemic Strokes despite Regular Anticoagulation: A Comparative Analysis of Direct Oral Anticoagulants and Warfarin in Treatment Outcomes

open access: yesInternational Journal of Clinical Practice
Objective. We aim to compare the outcomes between acute ischemic stroke (AIS) patients under vitamin K antagonist with those under direct oral anticoagulants (DOACs). Methods.
Sumeyye Cakmak, Ruken Simsekoglu
doaj   +1 more source

Home - About - Disclaimer - Privacy